Taysha Gene Therapies Inc (TSHA) — Capital Reinvestment Ratio
Taysha Gene Therapies Inc (TSHA) has a Capital Reinvestment Ratio of 0.16x as of December 2022, meaning it reinvests 0% of its operating cash flow ($14.28 Million) in capital expenditures ($2.31 Million). Check TSHA tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Taysha Gene Therapies Inc Capital Reinvestment Ratio (2019–2019)
This chart tracks Taysha Gene Therapies Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see TSHA operating cash flow.
Annual Capital Reinvestment Ratio for Taysha Gene Therapies Inc (2019–2019)
Year-by-year Capital Reinvestment Ratio for Taysha Gene Therapies Inc from 2019 to 2019. See Taysha Gene Therapies Inc (TSHA) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.61x | $135.00K | $82.00K | — |